We showed that ZEB2 mRNA overexpression is associated with poor outcome, and that concomitant overexpression of nuclear ZEB2 and cytoplasmic Hur at protein level correlates with shorter progression-free-survival and overall survival in ovarian cancer patients. This evidence concerns the gene ELAVL1 and ovarian cancer.